C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging(377 views) Acampa W, Di Taranto MD, Morgante A, Salvatore B, Evangelista L, Ricci F, Costanzo P, De Sisto E, Filardi PP, Petretta M, Fortunato G, Cuocolo A
Dipartimento di Scienze Biomorfologiche e Funzionali, Università degli Studi di Napoli Federico II, Consiglio Nazionale delle Ricerche, Napoli, Italy
Fondazione IRCCS SDN, Napoli, Italy
CEINGE Biotecnologie Avanzate S.C.a r.l., Napoli, Italy
Dipartimento di Biochimica e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Napoli, Italy
Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università degli Studi di Napoli Federico II, Napoli, Italy
Department of Biochemistry and Medical Biotechnology, University Federico II, Via Pansini 5, 80131, Napoli, Italy
References: The infl ammation: Lipoprotein cycle (2005) Atheroscler. Suppl., 6, pp. 15-2
Stoll, G., Bendszus, M., Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization (2006) Stroke, 37 (7), pp. 1923-1932. , DOI 10.1161/01.STR.0000226901.34927.10, PII 0000767020060700000068
Ng, C.J., Shih, D.M., Hama, S.Y., Villa, N., Navab, M., Reddy, S.T., The paraoxonase gene family and atherosclerosis (2005) Free Radical Biology and Medicine, 38 (2), pp. 153-163. , DOI 10.1016/j.freeradbiomed.2004.09.035, PII S0891584904008305
Primo-Parmo, S.L., Sorenson, R.C., Teiber, J., La Du, B.N., The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family (1996) Genomics, 33 (3), pp. 498-507. , DOI 10.1006/geno.1996.0225
Ng, C.J., Wadleigh, D.J., Gangopadhyay, A., Hama, S., Grijalva, V.R., Navab, M., Fogelman, A.M., Reddy, S.T., Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modifi cation of low density lipoprotein (2001) J. Biol. Chem., 276, pp. 44444-44449
Fortunato, G., Di Taranto, M.D., Bracale, U.M., Del Guercio, L., Carbone, F., Mazzaccara, C., Morgante, A.D., Salvatore, F., Decreased paraoxonase-2 expression in human carotids during the progression of atherosclerosis (2008) Arterioscler. Thromb. Vasc. Biol., 28, pp. 594-600
Levy, E., Trudel, K., Bendayan, M., Seidman, E., Delvin, E., Elchebly, M., Lavoie, J.-C., Sinnett, D., Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats (2007) American Journal of Physiology - Gastrointestinal and Liver Physiology, 293 (6), pp. G1252-G1261. , http://ajpgi.physiology.org/cgi/reprint/293/6/G1252, DOI 10.1152/ajpgi.00369.2007
Horke, S., Witte, I., Wilgenbus, P., Kruger, M., Strand, D., Forstermann, U., Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation (2007) Circulation, 115 (15), pp. 2055-2064. , DOI 10.1161/CIRCULATIONAHA.106.681700
Fortunato, G., Rubba, P., Panico, S., Trono, D., Tinto, N., Mazzaccara, C., De Michele, M., Sacchetti, L., A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women (2003) Atherosclerosis, 167 (1), pp. 141-148. , DOI 10.1016/S0021-9150(02)00423-9
Roest, M., Jansen, A.C.M., Barendrecht, A., Leus, F.R., Kastelein, J.J.P., Voorbij, H.A.M., Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia (2005) Clinical Biochemistry, 38 (2), pp. 123-127. , DOI 10.1016/j.clinbiochem.2004.10.005, PII S0009912004002887
Malin, R., Rantalaiho, V., Huang, X.-H., Wirta, O., Pasternack, A., Leinonen, J.S., Alho, H., Lehtimaki, T., Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects (1999) Human Genetics, 105 (1-2), pp. 179-180. , DOI 10.1007/s004399900074
Janka, Z., Juhasz, A., Rimanoczy, A., Boda, K., Marki-Zay, J., Kalman, J., Codon 311 (Cys → Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias (2002) Molecular Psychiatry, 7 (1), pp. 110-112. , DOI 10.1038/sj/mp/4001916
Fortunato, G., Marciano, E., Zarrilli, F., Mazzaccara, C., Intrieri, M., Calcagno, G., Vitale, D.F., Sacchetti, L., Paraoxonase and superoxide dismutase gene polymorphisms and noise-induced hearing loss (2004) Clinical Chemistry, 50 (11), pp. 2012-2018. , DOI 10.1373/clinchem.2004.037788
Martinelli, N., Girelli, D., Olivieri, O., Stranieri, C., Trabetti, E., Pizzolo, F., Friso, S., Corrocher, R., Interaction between smoking and PON2 Ser311 Cys polymorphism as a determinant of the risk of myocardial infarction (2004) European Journal of Clinical Investigation, 34 (1), pp. 14-20. , DOI 10.1111/j.1365-2362.2004.01292.x
Ridker, P.M., Hennekens, C.H., Buring, J.E., Rifai, N., C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women (2000) New England Journal of Medicine, 342 (12), pp. 836-843. , DOI 10.1056/NEJM200003233421202
Zebrack, J.S., Muhlestein, J.B., Horne, B.D., Anderson, J.L., C-reactive protein and angiographic coronary artery disease: Independent and additive predictors of risk in subjects with angina (2002) Journal of the American College of Cardiology, 39 (4), pp. 632-637. , DOI 10.1016/S0735-1097(01)01804-6, PII S0735109701018046
Tataru, M.-C., Heinrich, J., Junker, R., Schulte, H., Von Eckardstein, A., Assmann, G., Koehler, E., C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris (2000) European Heart Journal, 21 (12), pp. 1000-1008. , DOI 10.1053/euhj.1999.1981
Azar, R.R., Aoun, G., Fram, D.B., Waters, D.D., Wu, A.H.B., Kiernan, F.J., Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests (2000) American Journal of Cardiology, 86 (2), pp. 205-207. , DOI 10.1016/S0002-9149(00)00856-0, PII S0002914900008560
Shehadeh, J., Lewis, B.S., Weisz, G., David, M., Ashkenazi, T., Halon, D.A., Relation between C-reactive protein, treadmill exercise testing, and inducible myocardial ischemia (2004) American Journal of Cardiology, 93 (5), pp. 614-617. , DOI 10.1016/j.amjcard.2003.11.047, PII S0002914903016758
Beattie, M.S., Shlipak, M.G., Liu, H., Browner, W.S., Schiller, N.B., Whooley, M.A., C-reactive protein and ischemia in users and nonusers of β-blockers and statins: Data from the heart and soul study (2003) Circulation, 107 (2), pp. 245-250. , DOI 10.1161/01.CIR.0000044387.23578.E9
Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P., Hennekens, C.H., Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men (1997) New England Journal of Medicine, 336 (14), pp. 973-979. , DOI 10.1056/NEJM199704033361401
Klocke, F.J., Baird, M.G., Lorell, B.H., Bateman, T.M., Messer, J.V., Berman, D.S., O'Gara, P.T., Russell, R.O., ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - Executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines (2003) Circulation, 108, pp. 1404-1418. , American College of Cardiology
American Society for Nuclear Cardiology
Acampa, W., Petretta, M., Florimonte, L., Mattera, A., Cuocolo, A., Prognostic value of exercise cardiac tomography performed late after percutaneous coronary intervention in symptomatic and symptom-free patients (2003) American Journal of Cardiology, 91 (3), pp. 259-263. , DOI 10.1016/S0002-9149(02)03151-X, PII S000291490203151X
Germano, G., Kavanagh, P.B., Waechter, P., Areeda, J., Van Kriekinge, S., Sharir, T., Lewin, H.C., Berman, D.S., A new algorithm for the quantitation of myocardial perfusion SPECT. I: Technical principles and reproducibility (2000) Journal of Nuclear Medicine, 41 (4), pp. 712-719
Berman, D.S., Abidov, A., Kang, X., Hayes, S.W., Friedman, J.D., Sciammarella, M.G., Cohen, I., Hachamovitch, R., Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation (2004) Journal of Nuclear Cardiology, 11 (4), pp. 414-423. , DOI 10.1016/j.nuclcard.2004.03.033, PII S1071358104001394
Sharir, T., Germano, G., Kang, X., Lewin, H.C., Miranda, R., Cohen, I., Agafitei, R.D., Berman, D.S., Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: Risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction (2001) Journal of Nuclear Medicine, 42 (6), pp. 831-837
Oliveira, S.A., Mansur, A.P., Ribeiro, C.C., Ramires, J.A.F., Annichino-Bizzacchi, J.M., PON1 M/L55 mutation protects high-risk patients against coronary artery disease (2004) International Journal of Cardiology, 94 (1), pp. 73-77. , DOI 10.1016/j.ijcard.2003.05.011, PII S0167527303003437
Rios, D.L., D'Onofrio, L.O., Cerqueira, C.C., Bonfim-Silva, R., Carvalho, H.G., Santos-Filho, A., Galvão-Castro, B., Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: Evidence for gender interaction among Brazilians (2007) Clin. Chem. Lab. Med., 45, pp. 874-878
Troughton, J.A., Woodside, J.V., Yarnell, J.W.G., Arveiler, D., Amouyel, P., Ferrieres, J., Ducimetiere, P., Luc, G., Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: The PRIME study (2008) Atherosclerosis, 197 (2), pp. 556-563. , DOI 10.1016/j.atherosclerosis.2007.08.019, PII S0021915007005291
Wheeler, J.G., Keavney, B.D., Watkins, H., Collins, R., Danesh, J., Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: Meta-analysis of 43 studies (2004) Lancet, 363 (9410), pp. 689-695. , DOI 10.1016/S0140-6736(04)15642-0, PII S0140673604156420
Malin, R., Knuuti, J., Janatuinen, T., Laaksonen, R., Vesalainen, R., Nuutila, P., Jokela, H., Lehtimdie
ki, T., Paraoxonase gene polymorphisms and coronary reactivity in young healthy men (2001) J. Mol. Med., 79, pp. 449-458
Salonen, J.T., Malin, R., Tuomainen, T.P., Nyyssönen, K., Lakka, T.A., Lehtim̈ki, T., Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: Prospective nested case-control study (1999) BMJ, 319, pp. 487-489
Malin, R., Jarvinen, O., Sisto, T., Koivula, T., Lehtimaki, T., Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis (2001) Atherosclerosis, 157 (2), pp. 301-307. , DOI 10.1016/S0021-9150(00)00728-0, PII S0021915000007280
Malin, R., Laine, S., Rantalaiho, V., Wirta, O., Pasternack, A., Jokela, H., Alho, H., Lehtimaki, T., Lipid peroxidation is increased in paraoxonase L55 homozygotes compared with M-allele carriers (2001) Free Radical Research, 34 (5), pp. 477-484
MacKness, B., MacKness, M.I., Arrol, S., Turkie, W., Durrington, P.N., Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification (1998) FEBS Letters, 423 (1), pp. 57-60. , DOI 10.1016/S0014-5793(98)00064-7, PII S0014579398000647
Kivimaki, M., Lawlor, D.A., Smith, G.D., Eklund, C., Hurme, M., Lehtimaki, T., Viikari, J.S.A., Raitakari, O.T., Variants in the CRP gene as a measure of lifelong differences in average C-reactive protein levels: The Cardiovascular Risk in Young Finns Study, 1980-2001 (2007) American Journal of Epidemiology, 166 (7), pp. 760-764. , DOI 10.1093/aje/kwm151
Rontu, R., Ojala, P., Hervonen, A., Goebeler, S., Karhunen, P.J., Nikkilä, M., Kunnas, T., Lehtim̈ki, T., Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians (2006) Clin. Endocrinol., 64, pp. 265-270
Bhattacharyya, T., Nicholls, S.J., Topol, E.J., Zhang, R., Yang, X., Schmitt, D., Fu, X., Hazen, S.L., Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk (2008) JAMA - Journal of the American Medical Association, 299 (11), pp. 1265-1276. , http://jama.ama-assn.org/cgi/reprint/299/11/1265, DOI 10.1001/jama.299.11.1265
Ng, C. J., Shih, D. M., Hama, S. Y., Villa, N., Navab, M., Reddy, S. T., The paraoxonase gene family and atherosclerosis (2005) Free Radical Biology and Medicine, 38 (2), pp. 153-163. , DOI 10. 1016/j. freeradbiomed. 2004. 09. 035, PII S0891584904008305
Primo-Parmo, S. L., Sorenson, R. C., Teiber, J., La Du, B. N., The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family (1996) Genomics, 33 (3), pp. 498-507. , DOI 10. 1006/geno. 1996. 0225
Ng, C. J., Wadleigh, D. J., Gangopadhyay, A., Hama, S., Grijalva, V. R., Navab, M., Fogelman, A. M., Reddy, S. T., Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modifi cation of low density lipoprotein (2001) J. Biol. Chem., 276, pp. 44444-44449
Ridker, P. M., Hennekens, C. H., Buring, J. E., Rifai, N., C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women (2000) New England Journal of Medicine, 342 (12), pp. 836-843. , DOI 10. 1056/NEJM200003233421202
Zebrack, J. S., Muhlestein, J. B., Horne, B. D., Anderson, J. L., C-reactive protein and angiographic coronary artery disease: Independent and additive predictors of risk in subjects with angina (2002) Journal of the American College of Cardiology, 39 (4), pp. 632-637. , DOI 10. 1016/S0735-1097 (01) 01804-6, PII S0735109701018046
Tataru, M. -C., Heinrich, J., Junker, R., Schulte, H., Von Eckardstein, A., Assmann, G., Koehler, E., C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris (2000) European Heart Journal, 21 (12), pp. 1000-1008. , DOI 10. 1053/euhj. 1999. 1981
Azar, R. R., Aoun, G., Fram, D. B., Waters, D. D., Wu, A. H. B., Kiernan, F. J., Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests (2000) American Journal of Cardiology, 86 (2), pp. 205-207. , DOI 10. 1016/S0002-9149 (00) 00856-0, PII S0002914900008560
Beattie, M. S., Shlipak, M. G., Liu, H., Browner, W. S., Schiller, N. B., Whooley, M. A., C-reactive protein and ischemia in users and nonusers of -blockers and statins: Data from the heart and soul study (2003) Circulation, 107 (2), pp. 245-250. , DOI 10. 1161/01. CIR. 0000044387. 23578. E9
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., Hennekens, C. H., Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men (1997) New England Journal of Medicine, 336 (14), pp. 973-979. , DOI 10. 1056/NEJM199704033361401
Klocke, F. J., Baird, M. G., Lorell, B. H., Bateman, T. M., Messer, J. V., Berman, D. S., O'Gara, P. T., Russell, R. O., ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - Executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines (2003) Circulation, 108, pp. 1404-1418. , American College of Cardiology
Berman, D. S., Abidov, A., Kang, X., Hayes, S. W., Friedman, J. D., Sciammarella, M. G., Cohen, I., Hachamovitch, R., Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation (2004) Journal of Nuclear Cardiology, 11 (4), pp. 414-423. , DOI 10. 1016/j. nuclcard. 2004. 03. 033, PII S1071358104001394
Oliveira, S. A., Mansur, A. P., Ribeiro, C. C., Ramires, J. A. F., Annichino-Bizzacchi, J. M., PON1 M/L55 mutation protects high-risk patients against coronary artery disease (2004) International Journal of Cardiology, 94 (1), pp. 73-77. , DOI 10. 1016/j. ijcard. 2003. 05. 011, PII S0167527303003437
Rios, D. L., D'Onofrio, L. O., Cerqueira, C. C., Bonfim-Silva, R., Carvalho, H. G., Santos-Filho, A., Galv o-Castro, B., Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: Evidence for gender interaction among Brazilians (2007) Clin. Chem. Lab. Med., 45, pp. 874-878
Troughton, J. A., Woodside, J. V., Yarnell, J. W. G., Arveiler, D., Amouyel, P., Ferrieres, J., Ducimetiere, P., Luc, G., Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: The PRIME study (2008) Atherosclerosis, 197 (2), pp. 556-563. , DOI 10. 1016/j. atherosclerosis. 2007. 08. 019, PII S0021915007005291
Wheeler, J. G., Keavney, B. D., Watkins, H., Collins, R., Danesh, J., Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: Meta-analysis of 43 studies (2004) Lancet, 363 (9410), pp. 689-695. , DOI 10. 1016/S0140-6736 (04) 15642-0, PII S0140673604156420
Salonen, J. T., Malin, R., Tuomainen, T. P., Nyyss nen, K., Lakka, T. A., Lehtim ki, T., Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: Prospective nested case-control study (1999) BMJ, 319, pp. 487-489
C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(295 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote
Testino G, Leone S, Fagoonee S, Del Bas JM, Rodriguez B, Puiggros F, Marine S, Rodriguez MA, Morina D, Armengol L, Caimari A, Arola L, Cimini FA, Barchetta I, Carotti S, Bertoccini L, Baroni MG, Vespasiani-gentilucci U, Cavallo MG, Morini S, Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-stevenson V, Whalen E, Hoofnagle A, Mason M, Gersuk V, Yeh MM, Kowdley KV, Lee SM, Jun DW, Cho YK, Jang KS, Kucukazman M, Ata N, Dal K, Yeniova AO, Kefeli A, Basyigit S, Aktas B, Akin KO, Agladioglu K, Ure OS, Topal F, Nazligul Y, Beyan E, Ertugrul DT, Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA, Fallo F, Goto Y, Ray MB, Mendenhall CL, French SW, Gartside PS Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease(596 views) Hepatology (ISSN: 1827-1669electronic, 0026-4806linking), 1988 Sep; 83120693611123109(5): 1019-1026. Impact Factor:0.913 ViewExport to BibTeXExport to EndNote
100 Records (91 excluding Abstracts). Total impact factor: 408.383 (381.005 excluding Abstracts). Total 5 year impact factor: 346.178 (317.688 excluding Abstracts).